Mosaic ImmunoEngineering (CPMV) just unveiled an announcement.
Mosaic ImmunoEngineering, Inc. has revised the employment agreement with its CFO, Paul Lytle, transitioning him to a part-time role with a maximum of eight hours monthly for a $1,600 fee starting June 1, 2024. Additionally, Lytle’s accrued unpaid salary will be compensated following a successful capital raise of at least $4 million, at which point he will also receive restricted stock units amounting to 20% of this deferred salary.
Learn more about CPMV stock on TipRanks’ Stock Analysis page.
